Allogene Therapeutics, Inc. · NASDAQ:ALLO
David D. Chang, M.D., Ph.D. reported a 5.00% stake in Allogene Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 8, 2025
David D. Chang, M.D., Ph.D. reported a 5.00% stake in Allogene Therapeutics, Inc., 11,136,728 shares, as a passive investor on Jun 30, 2025. Filed Aug 8, 2025 (Schedule 13G/A).
- Stake
- 5.00%
- Shares
- 11,136,728
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| David D. Chang, M.D., Ph.D. | 5.00% | 11,136,728 |
| Chang 2006 Family Trust | 0.50% | 1,201,108 |
| JEC 2019 Trust | 0.40% | 856,044 |
| RTC 2019 Trust | 0.40% | 856,044 |
Source
Related
- Allogene Therapeutics, Inc.
- David D. Chang, M.D., Ph.D.
- Allogene Therapeutics, Inc. shareholders
- Schedule 13G/A · David D. Chang, M.D., Ph.D. · May 13, 2026
- Schedule 13G · David D. Chang, M.D., Ph.D. · Feb 13, 2026
- Schedule 13G/A · David D. Chang, M.D., Ph.D. · Nov 12, 2025
- Schedule 13G/A · David D. Chang, M.D., Ph.D. · May 9, 2025
- Schedule 13G/A · David D. Chang, M.D., Ph.D. · Feb 13, 2025
- Schedule 13D/A · Tpg Gp A, LLC · Sep 30, 2026
- Form 4 · Douglas Earl Martin · Aug 25, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · Arie Belldegrun, M.D. · Aug 7, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026